A detailed history of American International Group, Inc. transactions in Pds Biotechnology Corp stock. As of the latest transaction made, American International Group, Inc. holds 13,952 shares of PDSB stock, worth $41,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,952
Previous 13,899 0.38%
Holding current value
$41,158
Previous $69,000 20.29%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.85 - $6.59 $204 - $349
53 Added 0.38%
13,952 $55,000
Q4 2023

Feb 13, 2024

SELL
$3.95 - $6.58 $221 - $368
-56 Reduced 0.4%
13,899 $69,000
Q3 2023

Nov 13, 2023

BUY
$4.8 - $6.4 $2,385 - $3,180
497 Added 3.69%
13,955 $70,000
Q2 2023

Aug 04, 2023

BUY
$5.03 - $9.9 $67,693 - $133,234
13,458 New
13,458 $67,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $84M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.